ArticleObesity science & practice2024

Semaglutide 2.4 mg clinical outcomes in patients with obesity or overweight in a real-world setting: A 6-month retrospective study in the United States (SCOPE).

Aleksandrina Ruseva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.